{
  "doc_id": "16116131",
  "title": "rTMS of supplementary motor area modulates therapy-induced dyskinesias in Parkinson disease.",
  "body": "The neural mechanisms and circuitry involved in levodopa-induced dyskinesia are unclear. Using repetitive transcranial magnetic stimulation (rTMS) over the supplementary motor area (SMA) in a group of patients with advanced Parkinson disease, the authors investigated whether modulation of SMA excitability may result in a modification of a dyskinetic state induced by continuous apomorphine infusion. rTMS at 1 Hz was observed to markedly reduce drug-induced dyskinesias, whereas 5-Hz rTMS induced a slight but not significant increase.",
  "entities": [
    {
      "id": "D004409",
      "type": "DiseaseOrPhenotypicFeature",
      "mentions": [
        {
          "text": "dyskinesias",
          "passage_index": 0,
          "passage_offset": 0,
          "char_offset": 59,
          "length": 11
        },
        {
          "text": "dyskinesia",
          "passage_index": 1,
          "passage_offset": 93,
          "char_offset": 158,
          "length": 10
        },
        {
          "text": "dyskinetic",
          "passage_index": 1,
          "passage_offset": 93,
          "char_offset": 434,
          "length": 10
        },
        {
          "text": "drug-induced dyskinesias",
          "passage_index": 1,
          "passage_offset": 93,
          "char_offset": 540,
          "length": 24
        }
      ]
    },
    {
      "id": "D010300",
      "type": "DiseaseOrPhenotypicFeature",
      "mentions": [
        {
          "text": "Parkinson disease",
          "passage_index": 0,
          "passage_offset": 0,
          "char_offset": 74,
          "length": 17
        },
        {
          "text": "Parkinson disease",
          "passage_index": 1,
          "passage_offset": 93,
          "char_offset": 317,
          "length": 17
        }
      ]
    },
    {
      "id": "D007980",
      "type": "ChemicalEntity",
      "mentions": [
        {
          "text": "levodopa",
          "passage_index": 1,
          "passage_offset": 93,
          "char_offset": 141,
          "length": 8
        }
      ]
    },
    {
      "id": "9606",
      "type": "OrganismTaxon",
      "mentions": [
        {
          "text": "patients",
          "passage_index": 1,
          "passage_offset": 93,
          "char_offset": 294,
          "length": 8
        }
      ]
    },
    {
      "id": "D001058",
      "type": "ChemicalEntity",
      "mentions": [
        {
          "text": "apomorphine",
          "passage_index": 1,
          "passage_offset": 93,
          "char_offset": 473,
          "length": 11
        }
      ]
    }
  ],
  "relations": [
    {
      "id": "R0",
      "head_id": "D001058",
      "tail_id": "D004409",
      "type": "Positive_Correlation",
      "novel": "Novel"
    },
    {
      "id": "R1",
      "head_id": "D007980",
      "tail_id": "D004409",
      "type": "Positive_Correlation",
      "novel": "No"
    }
  ]
}